DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Chandra Bhagat Pharma Ltd (CBPL) share price today?

Chandra Bhagat Pharma Ltd (CBPL) is trading at ₹40 on the BSE, up 0.00% on the day. Source: DocStoX.

What is the PE ratio of Chandra Bhagat Pharma Ltd?

Chandra Bhagat Pharma Ltd has a price-to-earnings (PE) ratio of 9.9 in the Healthcare sector.

What is the market capitalisation of Chandra Bhagat Pharma Ltd?

Chandra Bhagat Pharma Ltd has a market capitalisation of approximately ₹30 crore.

Is Chandra Bhagat Pharma Ltd a profitable company?

Chandra Bhagat Pharma Ltd generates a return on equity of 9.2% with a net profit margin of 2.6%. That is a modest return on shareholder capital.

What is the 52-week high and low of CBPL?

Chandra Bhagat Pharma Ltd (CBPL) has traded between ₹29.7 and ₹52.99 over the past 52 weeks, against a current price of ₹40.

Chandra Bhagat Pharma Ltd

₹40.00▲ +0.00 (+0.00%)

CBPL·BSE·Healthcare

Market Cap

30.18 Cr

PE Ratio

9.90

Volume

2,000

Day High - Low

40.00 - 40.00

52W High-Low

52.99 - 29.70

₹40.00▲ +0.00 (+0.00%)

Market Cap30.18 Cr

PE Ratio9.90

Volume2,000

Day High - Low40.00 - 40.00

52W High-Low52.99 - 29.70

Chandra Bhagat Pharma Ltd (CBPL): company summary

The company's annual revenue rose 34.1% to ₹116 crore, while annual net profit surged 254.7% to ₹3 crore.

Chandra Bhagat Pharma Ltd (CBPL) is a micro-cap Healthcare company valued at ₹30 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move: Chandra Bhagat Pharma Ltd last traded at ₹40, unchanged on the day.
Financial performance: The company's annual revenue rose 34.1% to ₹116 crore, while annual net profit surged 254.7% to ₹3 crore. The latest quarter saw revenue jump 313.6% to ₹91 crore, with net profit remaining at ₹3 crore, matching the previous year's quarter.
Valuation multiples: The stock trades at 9.9 times earnings, a discount to the Healthcare median of 32.0, 1.02 times book value.
Things to watch: The stock is 24.5% below its 52-week high. Net profit margin improved to 2.6% from 1.0% but remains low. Promoter holding is at 73.02%, with no foreign or domestic institutional participation.
Where it stands: The company's net profit margin rose 1.6 percentage points to 2.6%, while revenue grew 34.1% annually. The stock is 24.5% below its 52-week high.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score

6.3/10

Fair

Fair Value

ROE

9.20%

Average

P/E

9.90x

Cheap

Debt / Equity

0.50

Moderate

Industry

Healthcare

Pharmaceuticals

Overall View

Fair

Price performance

52W₹29.70

₹52.99

DocStoX take

Supported by growth (8.1) and valuation (7.9), but weakest on momentum (4.2).

DocStoX score

Low confidence

6.3

/10

Fair

Quality

Modest

ROE 9.2%

Valuation

Cheap

P/E 9.9×

Growth

Strong

Revenue +10.4% 5Y CAGR

Risk

Moderate

D/E 0.50

Momentum

Soft

44% of 52-week range

DocStoX research

Our verdict

Fairly Valued

Fair value not available

Current price

₹40

Upside / Downside

—

Implied CAGR

—

Priced in by the market

Uncertainty

—

Est. confidence

At a glance

Market Cap

₹30 Cr

52W High / Low

₹53 / ₹30

Dividend Yield

0.00%

Promoter Holding

73.02%

EPS (TTM)

₹4.04

Book Value

₹43.90

Key highlights

Profit compounding 45% a year
Profitable in all of the last 5 years
Undemanding at 10× earnings
Small ₹30 cr company — thinner liquidity

3 Positives1 Watchout

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Explore Chandra Bhagat Pharma Ltd’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.

Chandra Bhagat Pharma Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

SUN PHARMACEUTICAL IND L DIVI S LABORATORIES LTD TORRENT PHARMACEUTICALS L LAURUS LABS LIMITED ZYDUS LIFESCIENCES LTD APOLLO HOSPITALS ENTER. L CIPLA LTD DR. REDDY S LABORATORIES AUROBINDO PHARMA LTD MANKIND PHARMA LIMITED LUPIN LIMITED MANIPAL HEALTH ENTERPRI L

Compare Chandra Bhagat Pharma Ltd with peers

Chandra Bhagat Pharma Ltd vs SUN PHARMACEUTICAL IND L Chandra Bhagat Pharma Ltd vs DIVI S LABORATORIES LTD Chandra Bhagat Pharma Ltd vs TORRENT PHARMACEUTICALS L Chandra Bhagat Pharma Ltd vs LAURUS LABS LIMITED Chandra Bhagat Pharma Ltd vs ZYDUS LIFESCIENCES LTD Chandra Bhagat Pharma Ltd vs APOLLO HOSPITALS ENTER. L

Related tools & concepts

Value Chandra Bhagat Pharma Ltd with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earnings Return on Equity (ROE)Profitability ROCECapital efficiency Debt to EquityLeverage P/B RatioPrice to book Net Profit MarginBottom-line efficiency DCF / Intrinsic ValueEstimate fair value CAGR CalculatorAnnualised return Dividend YieldIncome on price Position SizeRisk-based sizing Brokerage CalculatorCharges on a trade SIP CalculatorSystematic investing

Explore further

CBPL newsLatest coverage & filings Open screenerFilter the whole market